[go: up one dir, main page]

NO984166L - Sequence combination of ° estrogen / progesterone antagonists for hormone replacement therapy - Google Patents

Sequence combination of ° estrogen / progesterone antagonists for hormone replacement therapy

Info

Publication number
NO984166L
NO984166L NO984166A NO984166A NO984166L NO 984166 L NO984166 L NO 984166L NO 984166 A NO984166 A NO 984166A NO 984166 A NO984166 A NO 984166A NO 984166 L NO984166 L NO 984166L
Authority
NO
Norway
Prior art keywords
replacement therapy
hormone replacement
estrogen
sequence combination
progesterone antagonists
Prior art date
Application number
NO984166A
Other languages
Norwegian (no)
Other versions
NO984166D0 (en
NO324613B1 (en
Inventor
Kristof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO984166D0 publication Critical patent/NO984166D0/en
Publication of NO984166L publication Critical patent/NO984166L/en
Publication of NO324613B1 publication Critical patent/NO324613B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention concerns a medicament containing a combination of individual metering units of an oestrogen and individual metering units of a competitive progesterone antagonist for the separate sequential administration thereof, the medicament being used for hormone replacement therapy. The invention further concerns a pack containing these medicaments.
NO19984166A 1996-03-11 1998-09-10 Use of a Sequence Combination of Estrogen / Progesterone Antagonists to Prepare a Drug for Hormone Replacement Therapy NO324613B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19610635A DE19610635A1 (en) 1996-03-11 1996-03-11 Sequential estrogen / progesterone antagonist combination for hormone replacement therapy
PCT/DE1997/000580 WO1997033589A1 (en) 1996-03-11 1997-03-11 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy

Publications (3)

Publication Number Publication Date
NO984166D0 NO984166D0 (en) 1998-09-10
NO984166L true NO984166L (en) 1998-09-10
NO324613B1 NO324613B1 (en) 2007-11-26

Family

ID=7788657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984166A NO324613B1 (en) 1996-03-11 1998-09-10 Use of a Sequence Combination of Estrogen / Progesterone Antagonists to Prepare a Drug for Hormone Replacement Therapy

Country Status (16)

Country Link
EP (1) EP0889727B1 (en)
JP (1) JP2000506175A (en)
KR (1) KR19990087672A (en)
AT (1) ATE319454T1 (en)
AU (1) AU2691197A (en)
BR (1) BR9708162A (en)
CA (1) CA2248841C (en)
DE (2) DE19610635A1 (en)
DK (1) DK0889727T3 (en)
ES (1) ES2260792T3 (en)
HU (1) HUP9901474A3 (en)
IL (1) IL126176A (en)
NO (1) NO324613B1 (en)
PL (1) PL328809A1 (en)
PT (1) PT889727E (en)
WO (1) WO1997033589A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (en) * 1998-07-28 2000-02-24 Jenapharm Gmbh Use of biogenic estrogens for hormone replacement therapy
NZ517469A (en) * 1999-08-31 2004-01-30 Jenapharm Gmbh & Co Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (HRT)
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis
ATE288303T1 (en) * 2000-11-30 2005-02-15 Pfizer Prod Inc ESTROGEN AGONIST-ANTAGONIST AND TESTOSTERONE COMPOSITION FOR TREATING DECREASING TESTOSTERONE LEVELS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Also Published As

Publication number Publication date
AU2691197A (en) 1997-10-01
HUP9901474A2 (en) 1999-09-28
NO984166D0 (en) 1998-09-10
PT889727E (en) 2006-07-31
CA2248841C (en) 2008-07-22
IL126176A0 (en) 1999-05-09
WO1997033589A1 (en) 1997-09-18
ES2260792T3 (en) 2006-11-01
HUP9901474A3 (en) 2000-02-28
CA2248841A1 (en) 1997-09-18
NO324613B1 (en) 2007-11-26
DE59712593D1 (en) 2006-05-04
IL126176A (en) 2004-12-15
DK0889727T3 (en) 2006-07-03
DE19610635A1 (en) 1997-09-18
JP2000506175A (en) 2000-05-23
EP0889727B1 (en) 2006-03-08
ATE319454T1 (en) 2006-03-15
KR19990087672A (en) 1999-12-27
PL328809A1 (en) 1999-02-15
EP0889727A1 (en) 1999-01-13
BR9708162A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
FI970260A7 (en) Progesterone antagonist and progestogen for the treatment of endometriosis and leiomyomata uteri
UA41401C2 (en) Pharmaceutical combined contraceptive agent
BR9709934A (en) Hormone replacement therapy kit and / or contraceptive use of daily dosage units consisting essentially of a progestogen and process of preparing a drug delivery system
EP1028715A4 (en) DOSAGE COMPOSITION FOR NASAL ADMINISTRATION AND METHOD FOR USE THEREOF
NL300381I2 (en) Estradiol valerate and dienogest
EE05506B1 (en) Drug delivery device, especially for administration of progestins and strogens
DK1001772T3 (en) Improved delivery of multiple doses of a drug
BR9814837A (en) Procedure and device for dosing a drug
CO5261567A1 (en) USE OF BIOGENIC STROGEN SULFAMATES IN A HORMONE REPLACEMENT THERAPY
EE04997B1 (en) Pharmaceutical composition containing loteprednol and antihistamines, a medicament containing these agents, a process for the preparation of the medicament and use of a combination of these agents
JO2506B1 (en) A device for the administration of pressurized metered dose aerosols in hydrofluoroalkane propelants
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
NO984166L (en) Sequence combination of ° estrogen / progesterone antagonists for hormone replacement therapy
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE60025264D1 (en) DOSAGE CONTAINER FOR POWDERED MEDICAMENTS
JP2001513566A5 (en)
DE50005282D1 (en) MEDICINE AND MATCHED COMBINATION OF MEDICINES
DK0942729T3 (en) Use of NK-1 receptor antagonists for the treatment of stress disorders
SI20851B (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
MX9704527A (en) TRANSDERMIC SYSTEM OF SIMULTANEOUS ADMINISTRATION OF SEVERAL ACTIVE PRINCIPLES.
ECSP003721A (en) A PHARMACEUTICAL COMPOSITION TO BE USED AS AN CONTRACEPTIVE